AstraZeneca
AZN
#62
Rank
HK$2.063 T
Marketcap
HK$1,330
Share price
-0.99%
Change (1 day)
15.78%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): HK$54.30

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is HK$54.50. In 2024 the company made an earnings per share (EPS) of HK$35.60 an increase over its 2023 EPS that were of HK$30.11.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$54.30
2024HK$35.6018.23%
2023HK$30.1181.13%
2022HK$16.63631.03%
2021HK$2.27-88.11%
2020HK$19.13136.89%
2019HK$8.08-39.41%
2018HK$13.33-28.27%
2017HK$18.59-14.37%
2016HK$21.7024.11%
2015HK$17.49127.55%
2014HK$7.69-51.96%
2013HK$16.00-58.95%
2012HK$38.97-32.2%
2011HK$57.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.50 25.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.05 1.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.27-81.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$28.30-48.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$221.34 306.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$20.07-63.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$73.32 34.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$28.03-48.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.92-48.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$30.48-44.08%๐Ÿ‡ฌ๐Ÿ‡ง UK